Navigation Links
Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound
Date:3/2/2009

SOUTH SAN FRANCISCO, Calif., March 2 /PRNewswire-FirstCall/ -- Hana Biosciences (Nasdaq: HNAB) today announced that an Independent Data Monitoring Committee (IDMC) has completed a planned, pre-specified safety review of interim data from the ongoing pivotal rALLy clinical trial of Marqibo(R) (vincristine sulfate liposomes injection) for the treatment of adult acute lymphoblastic leukemia (ALL) in second relapse. The results of the IDMC review continue to support the acceptable safety profile observed with Marqibo in earlier studies and no new safety concerns were identified. The IDMC has recommended that the trial continue to completion per protocol.

The Company has accrued 42 patients, or 75 percent, of the total target enrollment of 56 evaluable patients. Recruitment is on target to complete in mid-2009. Results of the Company's planned interim efficacy analysis are forthcoming.

"The IDMC's recommendation to continue the rALLy trial represents an important milestone in the development of Marqibo and towards our goal of developing a therapeutic for this very sick patient population," stated Anne Hagey, M.D., vice president and chief medical officer of Hana Biosciences. "Thanks to our enthusiastic and committed investigators, patient enrollment remains on track. We target The 2009 American Society of Hematology Annual Meeting for a complete data presentation and look forward to submitting a New Drug Application for accelerated approval of Marqibo in 2010."

The interim analysis was designed to assess the safety data of the trial collected to date and also focus on logistical issues such as accrual, retention, and quality of clinical and laboratory data. This interim assessment was based upon a planned evaluation of safety data from the first 29 patients in the study who received at least one c
'/>"/>

SOURCE Hana Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...PRNewswire-Asia/ -- Simcere Pharmaceutical Group,(...ing pharmaceutical company,specializing in the dev...generic and proprietary pharmaceuticals in China, ... Biological Technology Stock Co., Ltd. ("Jiangsu,Y...cts in order to conduct an,internal inspection and...
(Date:12/1/2009)...wire-FirstCall/ -- Patient Safety Technologies, In... it has appointed Marc L. Rose, CPA(PA), to the po...orporate Secretary, replacing Mary M. Lay, who has...ient Safety Technologies, Inc., Mr. Rose was Vice ...rer and Corporate Secretary of Protalex, Inc., a p...
(Date:12/1/2009)...ire/ -- Reportlinker.com announces that a new mark...,, HPLC Systems & Accessories - A World Ma...164366/HPLC-Systems--Accessories---A-World-Market-...graphy has emerged as a workhorse technology in li...esearch and development, and industrial chemicals....
Breaking Medicine Technology:Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 3Reportlinker Adds HPLC Systems & Accessories - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 5Reportlinker Adds HPLC Systems & Accessories - A World Market Review 6Reportlinker Adds HPLC Systems & Accessories - A World Market Review 7Farmed fish may pose risk for mad cow disease 49033 1Farmed fish may pose risk for mad cow disease 49033 2Cannabis alters human DNA new study 49030 1Cannabis alters human DNA new study 49030 2Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 1Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 2Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 3Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 4
...es, Inc. today announced that it has signed a serv...to supply reagents for Osmetech,s recently launche...CD) System and the eSensor(R) XT-8 System for Warf...riLink is providing Osmetech with custom oligonucl...or(R) detection systems. , , "TriLink provides hi...
...rmaceutical,company focused on the discovery and d...me the significant global problem of microbial res...ine products NXL104 and NXL103 are,the subject of ...ical,Microbiology and Infectious Diseases (ECCMID)...i between 16th and 19th May 2009. , NXL104, No...
Other Medicine Technology:TriLink BioTechnologies, Inc. Announces Supply Agreement With Osmetech Molecular Diagnostics 2Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki 2Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki 3
(Date:12/2/2009)...inety-six percent of low-income mothers who partic...indicated a strong general feeling of distrust of ...owards men did not prevent them from entering into...rthermore, the union was often later described by ...or assertions of distrust and insecurity. The resu...
(Date:12/2/2009)..., Inc. (OTC Bulletin Board: CSBR), a U.S. Oncology...nical platform aimed at accelerating the developme...established an exclusive licensing agreement with ...sity,s wholly owned technology transfer company. ...pment and commercialization of TAR-1, a single-cha...
(Date:12/2/2009)...., Dec. 2 From more than 1,100 pho...ning, joy and peace, the LIFE Foundation has selec...d using the popular photo-sharing Web site flickr....ontage on the LIFE Foundation,s Web site at www.l...submitted one photo and a caption to Flickr.com du...
(Date:12/2/2009)...or Thursday, Dec. 3 ,, Head of Army,s Warrior...f Army Wounded Warriors; Army Embraces Reality of ...HINGTON, Dec. 2 The fol...tion on Disability: ,, WHAT: Wounded veterans...or (AW2) program,s National Organization on Disabi...
(Date:12/2/2009)...., Dec. 2 Watson Pharmac... it has completed the acquisition of Arrow Group f...reates a financially strong, global specialty phar...revenues and operations in more than 20 countries.... Watson shareholders as a result of this financial...
Breaking Medicine News(10 mins):Health News:Champions Biotechnology signs exclusive agreement with Tel Aviv University for cancer drug 2Health News:Wonders of Life Photo Contest Winners Announced 2Health News:Wonders of Life Photo Contest Winners Announced 3Health News:Wounded Vets, CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup 2Health News:Watson Completes Acquisition of Arrow Group 2Health News:Watson Completes Acquisition of Arrow Group 3Health News:Watson Completes Acquisition of Arrow Group 4Health News:Watson Completes Acquisition of Arrow Group 5
...odents shows the molecules help regulate appetite ... As you push your chair back from the Thanksgiving... intestine will be swarming through your bloodstre...searchers are hoping that one day variations of th...
...J., Nov. 26 Barr Pharmaceuticals, Inc. (NYSE: B...oratories, Inc., has initiated a challenge of the ...ix(R) (cyclobenzaprine hydrochloride) extended-rel...rsion of Amrix with the U.S. Food & Drug Admin...
...y transplant recipients with a serious complicatio...promptly cutting back on anti-rejection drugs redu...cording to a report in the November Clinical Jour...immunosuppression tapering approaches in BKVAN, an...
...ndance is key, researchers say, but they don,t kno...ews) -- Attending a weekly religious service, rega... by 20 percent compared to people who don,t attend...n and the threat of terrorism, people are looking ...
...ov. 26 NASA is investigating the best methods for...gned to help airplane pilots realize when they are...ue and distraction. , , (Logo: http://www.ne...ared spectroscopy, also know as fNIRS, and other i...
...,Nov. 26 MonoSol Rx, the developers of PharmFilm(...zing in dissolving thin film pharmaceutical produc...t and CEO, and Keith J. Kendall, executive vice pr... in New York City. , , , Event: 20th Annu...
Other Medicine News:Health News:Fat-Sensing Hormones Might Fight Obesity 2Health News:Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg 2Health News:Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg 3Health News:Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg 4Health News:Study compares strategies for BK virus nephropathy 2Health News:Religion May Help Extend Your Life 2Health News:Religion May Help Extend Your Life 3Health News:NASA Conducts Pilot Cognition Studies 2Health News:MonoSol Rx to Present at the 20th Annual Piper Jaffray Health Care Conference 2
3.5v Coaxial Ophthalmoscopes
Refraction System RT-2100
...T-300's accessory knob is positioned next to the c...n a hand's breadth of each other. Cylinder power u... "Sure-grip" knurls on the control knobs make them...ment of the controls themselves, this helps reduce...
Ultramatic RX Master PHOROPTOR Refracting Instrument - Minus Cylinder Black
Medicine Products: